{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:09:24Z","timestamp":1794305364184,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-023-02623-7","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T14:02:25Z","timestamp":1691762545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Preparation and Characterization of 3D-Printed Dose-Flexible Printlets of Tenofovir Disoproxil Fumarate"],"prefix":"10.1208","volume":"24","author":[{"given":"Canberk","family":"Kayalar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyaur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish","family":"Dharani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Khuroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew A.","family":"Kuttolamadom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3649-3874","authenticated-orcid":false,"given":"Mansoor A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"2623_CR1","unstructured":"UNAIDS: Global HIV and AIDS statistics\u2013fact sheet. 2021. https:\/\/www.unaids.org\/en\/resources\/fact-sheet.\u00a0Accessed 31 May 2022."},{"issue":"3","key":"2623_CR2","first-page":"174","volume":"39","author":"A Lloyd","year":"1996","unstructured":"Lloyd A. HIV infection and AIDS. P N G Med J. 1996;39(3):174\u201380.","journal-title":"P N G Med J"},{"issue":"4","key":"2623_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jacbts.2021.10.017","volume":"7","author":"L Kovacs","year":"2022","unstructured":"Kovacs L, Kress TC, de Chantem\u00e8le EJB. HIV, Combination antiretroviral therapy, and vascular diseases in men and women. JACC Basic Transl Sci. 2022;7(4):410\u201321. https:\/\/doi.org\/10.1016\/j.jacbts.2021.10.017.","journal-title":"JACC Basic Transl Sci"},{"key":"2623_CR4","doi-asserted-by":"publisher","first-page":"103896","DOI":"10.1016\/j.ebiom.2022.103896","volume":"77","author":"B Rod\u00e9s","year":"2022","unstructured":"Rod\u00e9s B, Cadi\u00f1anos J, Esteban-Cantos A, Rodr\u00edguez-Centeno J, Arribas JR. Ageing with HIV: challenges and biomarkers. EBioMedicine. 2022;77:103896. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103896.","journal-title":"EBioMedicine"},{"issue":"5","key":"2623_CR5","doi-asserted-by":"publisher","first-page":"e1244","DOI":"10.1542\/peds.2011-1740","volume":"129","author":"AL Buchanan","year":"2012","unstructured":"Buchanan AL, Montepiedra G, Sirois PA, Kammerer B, Garvie PA, Storm DS, et al. Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report. Pediatrics. 2012;129(5):e1244\u201351. https:\/\/doi.org\/10.1542\/peds.2011-1740.","journal-title":"Pediatrics"},{"issue":"4","key":"2623_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11904-009-0026-8","volume":"6","author":"J Haberer","year":"2009","unstructured":"Haberer J, Mellins C. Pediatric adherence to HIV antiretroviral therapy. Curr HIV\/AIDS Rep. 2009;6(4):194\u2013200. https:\/\/doi.org\/10.1007\/s11904-009-0026-8.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2623_CR7","doi-asserted-by":"publisher","first-page":"1654938","DOI":"10.1155\/2016\/1654938","volume":"2016","author":"AF Schlatter","year":"2016","unstructured":"Schlatter AF, Deathe AR, Vreeman RC. The need for pediatric formulations to treat children with HIV. AIDS Res Treat. 2016;2016:1654938. https:\/\/doi.org\/10.1155\/2016\/1654938.","journal-title":"AIDS Res Treat"},{"issue":"8","key":"2623_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.5863\/1551-6776-26.8.783","volume":"26","author":"C Lee","year":"2021","unstructured":"Lee C, Sapasap J, LaRochelle J, Smith RO, Badowski ME. Antiretroviral therapy in children and adolescents: a look into modern single tablet regimens. J Pediatr Pharmacol Ther. 2021;26(8):783\u201394. https:\/\/doi.org\/10.5863\/1551-6776-26.8.783.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"11","key":"2623_CR9","first-page":"8","volume":"46","author":"DM Lisi","year":"2021","unstructured":"Lisi DM. Pros and cons of pharmacy compounding. US Pharm. 2021;46(11):8\u201312.","journal-title":"US Pharm"},{"key":"2623_CR10","doi-asserted-by":"publisher","unstructured":"Gobetti C. Evaluation of physicochemical and microbiological stability of liquid preparation from tizanidine hydrochloride tablets-a hospital concern. Braz J Pharm Sci. 2021;57. https:\/\/doi.org\/10.1590\/s2175-97902020000418896.","DOI":"10.1590\/s2175-97902020000418896"},{"issue":"1\u20132","key":"2623_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijpharm.2018.02.015","volume":"541","author":"F Fina","year":"2018","unstructured":"Fina F, Madla CM, Goyanes A, Zhang J, Gaisford S, Basit AW. Fabricating 3D printed orally disintegrating printlets using selective laser sintering. Int J Pharm. 2018;541(1\u20132):101\u20137. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.02.015.","journal-title":"Int J Pharm"},{"key":"2623_CR12","doi-asserted-by":"publisher","unstructured":"Awad A, Fina F, Trenfield SJ, Patel P, Goyanes A, Gaisford S, et al. 3D printed pellets (miniprintlets): a novel, multi-drug, controlled release platform technology. Pharmaceutics. 2019;11(4). https:\/\/doi.org\/10.3390\/pharmaceutics11040148.","DOI":"10.3390\/pharmaceutics11040148"},{"issue":"6","key":"2623_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1208\/s12249-020-01775-0","volume":"21","author":"EM Mohamed","year":"2020","unstructured":"Mohamed EM, Barakh Ali SF, Rahman Z, Dharani S, Ozkan T, Kuttolamadom MA, et al. Formulation optimization of selective laser sintering 3D-printed tablets of clindamycin palmitate hydrochloride by response surface methodology. AAPS PharmSciTech. 2020;21(6):232. https:\/\/doi.org\/10.1208\/s12249-020-01775-0.","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"2623_CR14","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1086\/378068","volume":"37","author":"JE Gallant","year":"2003","unstructured":"Gallant JE, Deresinski S. Tenofovir disoproxil fumarate. Clin Infect Dis. 2003;37(7):944\u201350. https:\/\/doi.org\/10.1086\/378068.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2623_CR15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1128\/aac.42.3.612","volume":"42","author":"BL Robbins","year":"1998","unstructured":"Robbins BL, Srinivas RV, Kim C, Bischofberger N, Fridland A. Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA. Antimicrob Agents Chemother. 1998;42(3):612\u20137. https:\/\/doi.org\/10.1128\/aac.42.3.612.","journal-title":"Antimicrob Agents Chemother"},{"key":"2623_CR16","unstructured":"Viread\u00ae (tenofovir disoproxil fumarate) tablets: US package insert Accessed April 22 2022. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/021356s042,022577s002lbl.pdf"},{"issue":"2","key":"2623_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s0166-3542(97)00043-0","volume":"36","author":"AS Mulato","year":"1997","unstructured":"Mulato AS, Cherrington JM. Anti-HIV activity of adefovir (PMEA) and PMPA in combination with antiretroviral compounds: in vitro analyses. Antiviral Res. 1997;36(2):91\u20137. https:\/\/doi.org\/10.1016\/s0166-3542(97)00043-0.","journal-title":"Antiviral Res"},{"key":"2623_CR18","unstructured":"Guidelines for the use of antiretroviral agents in pediatric HIV infection. In: Services UDoHaH, editor. https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/PediatricGuidelines.pdf2020."},{"key":"2623_CR19","unstructured":"FDA: Viread\u00ae FDA label. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/021356s058,022577s014lbl.pdf Accessed May 31 2020."},{"issue":"6","key":"2623_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1208\/s12248-018-0225-6","volume":"20","author":"Z Rahman","year":"2018","unstructured":"Rahman Z, Barakh Ali SF, Ozkan T, Charoo NA, Reddy IK, Khan MA. Additive manufacturing with 3D printing: progress from bench to bedside. Aaps j. 2018;20(6):101. https:\/\/doi.org\/10.1208\/s12248-018-0225-6.","journal-title":"Aaps j"},{"key":"2623_CR21","doi-asserted-by":"publisher","first-page":"118651","DOI":"10.1016\/j.ijpharm.2019.118651","volume":"570","author":"SF Barakh Ali","year":"2019","unstructured":"Barakh Ali SF, Mohamed EM, Ozkan T, Kuttolamadom MA, Khan MA, Asadi A, et al. Understanding the effects of formulation and process variables on the printlets quality manufactured by selective laser sintering 3D printing. Int J Pharm. 2019;570:118651. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118651.","journal-title":"Int J Pharm."},{"key":"2623_CR22","doi-asserted-by":"publisher","first-page":"120059","DOI":"10.1016\/j.ijpharm.2020.120059","volume":"592","author":"R Hamed","year":"2021","unstructured":"Hamed R, Mohamed EM, Rahman Z, Khan MA. 3D-printing of lopinavir printlets by selective laser sintering and quantification of crystalline fraction by XRPD-chemometric models. Int J Pharm. 2021;592:120059. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.120059.","journal-title":"Int J Pharm"},{"issue":"6","key":"2623_CR23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/03639045.2020.1764027","volume":"46","author":"NA Charoo","year":"2020","unstructured":"Charoo NA, Barakh Ali SF, Mohamed EM, Kuttolamadom MA, Ozkan T, Khan MA, et al. Selective laser sintering 3D printing\u2013an overview of the technology and pharmaceutical applications. Drug Dev Ind Pharm. 2020;46(6):869\u201377. https:\/\/doi.org\/10.1080\/03639045.2020.1764027.","journal-title":"Drug Dev Ind Pharm"},{"key":"2623_CR24","unstructured":"FDA: Distributed manufacturing and point-of-care manufacturing of drugs. 2022. https:\/\/www.fda.gov\/media\/162157\/download?attachment. Accessed 1 May 2022."},{"issue":"4","key":"2623_CR25","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1021\/acs.cgd.5b00089","volume":"15","author":"ECdL Gomes","year":"2015","unstructured":"Gomes ECdL, Mussel WN, Resende JM, Fialho SL, Barbosa J, Carignani E, et al. Characterization of tenofovir disoproxil fumarate and its behavior under heating. Crystal Growth Des. 2015;15(4):1915\u201322. https:\/\/doi.org\/10.1021\/acs.cgd.5b00089.","journal-title":"Crystal Growth Des"},{"issue":"1","key":"2623_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10973-017-6910-3","volume":"132","author":"C-j Wu","year":"2018","unstructured":"Wu C-j, You J-z, Wang X-j. Thermal decomposition mechanism of tenofovir disoproxil fumarate. J Therm Anal Calorim. 2018;132(1):471\u201382. https:\/\/doi.org\/10.1007\/s10973-017-6910-3.","journal-title":"J Therm Anal Calorim"},{"issue":"1\u20132","key":"2623_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijpharm.2009.12.040","volume":"389","author":"Z Rahman","year":"2010","unstructured":"Rahman Z, Zidan AS, Habib MJ, Khan MA. Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design. Int J Pharm. 2010;389(1\u20132):186\u201394. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.12.040.","journal-title":"Int J Pharm"},{"issue":"2","key":"2623_CR28","doi-asserted-by":"publisher","first-page":"e0193292","DOI":"10.1371\/journal.pone.0193292","volume":"13","author":"H Alyami","year":"2018","unstructured":"Alyami H, Koner J, Huynh C, Terry D, Mohammed AR. Current opinions and recommendations of paediatric healthcare professionals\u2013the importance of tablets: emerging orally disintegrating versus traditional tablets. PLOS ONE. 2018;13(2):e0193292. https:\/\/doi.org\/10.1371\/journal.pone.0193292.","journal-title":"PLOS ONE"},{"issue":"7","key":"2623_CR29","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/jphp.12920","volume":"70","author":"NA Charoo","year":"2018","unstructured":"Charoo NA, Rahman Z, Ali AA. Is the demonstration of bioequivalence for clavulanic acid required in amoxicillin-clavulanic acid orally administered immediate-release products? J Pharm Pharmacol. 2018;70(7):883\u201392. https:\/\/doi.org\/10.1111\/jphp.12920.","journal-title":"J Pharm Pharmacol"},{"key":"2623_CR30","unstructured":"FDA: Guidance for industry\u2013orally disintegrating tablets. 2008. https:\/\/www.fda.gov\/media\/70877\/download.\u00a0Accessed 31 May 2022."},{"key":"2623_CR31","unstructured":"FDA: Dissolution methods\u2013tenofovir disoroxil fumerate. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/dissolution\/dsp_SearchResults.cfm.\u00a0Accessed 6 June 2022."},{"issue":"5","key":"2623_CR32","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1021\/cg1000667","volume":"10","author":"EH Lee","year":"2010","unstructured":"Lee EH, Smith DT, Fanwick PE, Byrn SR. Characterization and anisotropic lattice expansion\/contraction of polymorphs of tenofovir disoproxil fumarate. Cryst Growth Des. 2010;10(5):2314\u201322. https:\/\/doi.org\/10.1021\/cg1000667.","journal-title":"Cryst Growth Des"},{"key":"2623_CR33","doi-asserted-by":"crossref","unstructured":"Daimay Lin-Vien NC, William Fateley, Jeanette Grasselli. The handbook of infrared and raman characteristic frequencies of organic molecules. 1st ed. Academic Press; 1991.","DOI":"10.1016\/B978-0-08-057116-4.50007-9"},{"issue":"4","key":"2623_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.mseb.2012.11.007","volume":"178","author":"AL Saroj","year":"2013","unstructured":"Saroj AL, Singh RK, Chandra S. Studies on polymer electrolyte poly(vinyl) pyrrolidone (PVP) complexed with ionic liquid: effect of complexation on thermal stability, conductivity and relaxation behaviour. Mater Sci Eng, B. 2013;178(4):231\u20138. https:\/\/doi.org\/10.1016\/j.mseb.2012.11.007.","journal-title":"Mater Sci Eng, B"},{"issue":"1","key":"2623_CR35","first-page":"49","volume":"5","author":"A Sharma","year":"2010","unstructured":"Sharma A, Jain CP. Preparation and characterization of solid dispersions of carvedilol with PVP K30. Res Pharm Sci. 2010;5(1):49\u201356.","journal-title":"Res Pharm Sci"},{"issue":"3","key":"2623_CR36","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.xphs.2019.12.003","volume":"109","author":"S Dharani","year":"2020","unstructured":"Dharani S, Barakh Ali SF, Afrooz H, Mohamed EM, Cook P, Khan MA, et al. Development of methamphetamine abuse-deterrent formulations using sucrose acetate isobutyrate. J Pharm Sci. 2020;109(3):1338\u201346. https:\/\/doi.org\/10.1016\/j.xphs.2019.12.003.","journal-title":"J Pharm Sci"},{"issue":"3\u20134","key":"2623_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ejps.2013.07.004","volume":"50","author":"J Lee","year":"2013","unstructured":"Lee J, Boerrigter SX, Jung YW, Byun Y, Yuk SH, Byrn SR, et al. Organic vapor sorption method of isostructural solvates and polymorph of tenofovir disoproxil fumarate. Eur J Pharm Sci. 2013;50(3\u20134):253\u201362. https:\/\/doi.org\/10.1016\/j.ejps.2013.07.004.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"2623_CR38","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1021\/bp00014a008","volume":"8","author":"MDP Buera","year":"1992","unstructured":"Buera MDP, Levi G, Karel M. Glass transition in poly(vinylpyrrolidone): effect of molecular weight and diluents. Biotechnol Progress. 1992;8(2):144\u20138. https:\/\/doi.org\/10.1021\/bp00014a008.","journal-title":"Biotechnol Progress."},{"issue":"2\u20133","key":"2623_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/10408399109527543","volume":"30","author":"L Slade","year":"1991","unstructured":"Slade L, Levine H. Beyond water activity: recent advances based on an alternative approach to the assessment of food quality and safety. Crit Rev Food Sci Nutr. 1991;30(2\u20133):115\u2013360.","journal-title":"Crit Rev Food Sci Nutr."},{"issue":"9","key":"2623_CR40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2165\/00003088-200443090-00003","volume":"43","author":"BP Kearney","year":"2004","unstructured":"Kearney BP, Flaherty JF, Shah J. Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics. Clin Pharmacokinet. 2004;43(9):595\u2013612. https:\/\/doi.org\/10.2165\/00003088-200443090-00003.","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"2623_CR41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/qad.0000000000001744","volume":"32","author":"AT Podany","year":"2018","unstructured":"Podany AT, Bares SH, Havens J, Dyavar SR, O\u2019Neill J, Lee S, et al. Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide. AIDS. 2018;32(6):761\u20135. https:\/\/doi.org\/10.1097\/qad.0000000000001744.","journal-title":"AIDS"},{"issue":"10","key":"2623_CR42","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1681\/asn.2012080857","volume":"24","author":"J Tourret","year":"2013","unstructured":"Tourret J, Deray G, Isnard-Bagnis C. Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword? J Am Soc Nephrol. 2013;24(10):1519\u201327. https:\/\/doi.org\/10.1681\/asn.2012080857.","journal-title":"J Am Soc Nephrol"},{"key":"2623_CR43","unstructured":"FDA: guidance document- bioequivalence studies with pharmacokinetic endpoints for drugs submitted under an ANDA guidance for industry. 2021. https:\/\/www.fda.gov\/media\/87219\/download. Accessed May 31, 2022."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-023-02623-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-023-02623-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-023-02623-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T13:18:02Z","timestamp":1692710282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-023-02623-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["2623"],"URL":"https:\/\/doi.org\/10.1208\/s12249-023-02623-7","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"7 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"171"}}